These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2190239)

  • 41. Effect of CGS 19755, a competitive N-methyl-D-aspartate antagonist, on general anesthetic potency.
    Daniell LC
    Pharmacol Biochem Behav; 1991 Dec; 40(4):767-9. PubMed ID: 1840080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.
    Butelman ER
    Pharmacol Biochem Behav; 1989 Sep; 34(1):13-6. PubMed ID: 2696982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective depression of the segmental polysynaptic reflex by phencyclidine and its analogs in the rat in vitro: interaction with N-methyl-D-aspartate receptors.
    Ohno Y; Warnick JE
    J Pharmacol Exp Ther; 1990 Jan; 252(1):246-52. PubMed ID: 1967645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors.
    Martin DC; Plagenhoef M; Abraham J; Dennison RL; Aronstam RS
    Biochem Pharmacol; 1995 Mar; 49(6):809-17. PubMed ID: 7702639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus.
    Rogers BC; Tilson HA
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):445-53. PubMed ID: 2546291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
    Aram JA; Martin D; Tomczyk M; Zeman S; Millar J; Pohler G; Lodge D
    J Pharmacol Exp Ther; 1989 Jan; 248(1):320-8. PubMed ID: 2536430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
    Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.
    Ward L; Mason SE; Abraham WC
    Pharmacol Biochem Behav; 1990 Apr; 35(4):785-90. PubMed ID: 2189143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
    Butelman ER
    Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801.
    Lalies M; Middlemiss DN; Ransom R
    Neurosci Lett; 1988 Sep; 91(3):339-42. PubMed ID: 2847087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
    Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
    Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.
    Koek W; France CP
    Psychopharmacology (Berl); 2008 Aug; 199(2):191-8. PubMed ID: 18446324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia.
    Buchan A; Pulsinelli WA
    J Neurosci; 1990 Jan; 10(1):311-6. PubMed ID: 2405111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic cats.
    Foutz AS; Champagnat J; Denavit-Saubié M
    Eur J Pharmacol; 1988 Sep; 154(2):179-84. PubMed ID: 3068062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801.
    Schmidt CJ; Taylor VL
    Eur J Pharmacol; 1988 Oct; 156(1):111-20. PubMed ID: 2850205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonists at the NMDA recognition site and blockers of the associated ion channel induce spontaneous tail-flicks in the rat.
    Millan MJ
    Eur J Pharmacol; 1991 Oct; 203(2):315-8. PubMed ID: 1724759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
    Carlsson M; Svensson A
    Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.